Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

Baeten, D, Sieper, J, Braun, J et al. (10 more authors) (2015) Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. New England Journal of Medicine, 373 (26). pp. 2534-2548. ISSN 0028-4793

Abstract

Metadata

Authors/Creators:
  • Baeten, D
  • Sieper, J
  • Braun, J
  • Baraliakos, X
  • Dougados, M
  • Emery, P
  • Deodhar, A
  • Porter, B
  • Martin, R
  • Andersson, M
  • Mpofu, S
  • Richards, HB
  • Grp, M
Copyright, Publisher and Additional Information: From "New England Journal of Medicine. Baeten, D, Sieper, J, Braun, J, Baraliakos, X, Dougados, M, Emery, P, Deodhar, A, Porter, B, Martin, R, Andersson, M, Mpofu, S, Richards, HB and Grp, M. Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis, 373(26). pp. 2534-2548. Copyright © 2015, Massachusetts Medical Society. Reprinted with permission.
Dates:
  • Published: 24 December 2015
  • Accepted: 28 August 2015
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Clinical Musculoskeletal Medicine (LIRMM) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 17 Feb 2016 12:18
Last Modified: 24 Jun 2016 00:38
Published Version: http://dx.doi.org/10.1056/NEJMoa1505066
Status: Published
Publisher: Massachusetts Medical Society
Identification Number: https://doi.org/10.1056/NEJMoa1505066
Related URLs:

Share / Export

Statistics